PGNY Stock Analysis: Buy, Sell, or Hold?
PGNY - Progyny, Inc. Common Stock
$23.87
-0.25 (-1.04%)
ā¼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
24d
Get Alerted When PGNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
š HOLD: PGNY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
š HOLD: PGNY shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$34.97
Based on 6.2% avg growth
INTRINSIC VALUE TODAY
$21.71
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PGNY is currently trading at $23.87, which is considered oversold relative to its 30-day fair value range of $24.66 to $26.76. The stock's valuation (Forward PE: 12.1) is in line with its historical norms (13.2). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This pessimistic expectation contrasts with the company's recent 36.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PGNY is in a strong uptrend. The price is currently testing key support at $23.35. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PGNY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.91 (+29.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PGNY is in a strong uptrend. The price is currently testing key support at $23.35. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: PGNY has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $30.91 (+29.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$24.66 -
$26.76
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding PGNY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.5% below Wall St target ($30.91)
- CAUTION: 5-day price weakness (-5.4%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$24.66 -
$26.76
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$23.35
Resistance Level
$25.78
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
12.14
Wall Street Target
$30.91
(+29.5%)
Revenue Growth (YoY)
9.3%
Earnings Growth (YoY)
36.4%
Profit Margin
4.5%
Valuation Discount vs History
-2.6% cheaper
PE vs Historical
12.1 vs 13.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.6%
(market-implied from PE analysis)
1-Year Target
$23.25
(-3%)
2-Year Target
$22.64
(-5%)
3-Year Target
$22.06
(-8%)
3-Yr Target (if PE normalizes)
(PE: 12ā13)
$23.99
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 8.3%)
$55.71
(+133%)
Base:
(SPY PE: 12.1, Growth: 8.3%)
$30.32
(+27%)
Bear:
(PE: 10.3, Growth: 8.3%)
$25.77
(+8%)
š
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (40x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 39.56 | Current EPS (TTM): $0.62
Bull Case
$53.97
(+126%)
Analyst growth 100.0%, PE expands to 43.5
Base Case
$49.06
(+106%)
Market implied 100.0%, PE stable at 39.6
Bear Case
$16.68
(-30%)
Severe decline -20.0%, PE contracts to 33.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
š”
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.1 to 13.2
Stabilization Target:
$25.96
(+8.8%)
PE Expansion Potential:
+8.8%
Last updated: January 31, 2026 10:08 PM ET
Data refreshes hourly during market hours. Next update: 11:08 PM
Data refreshes hourly during market hours. Next update: 11:08 PM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PGNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Allison Swartz
SELL
599 shares
2025-09-04
Allison Swartz
SELL
2398 shares
2025-08-28
Allison Swartz
SELL
2398 shares
2025-08-28
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$95 | 61 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$327 | 58 HOLD |
|
UNH
UnitedHealth Group Incorā¦ |
STRONG BUY
27 analysts |
$394 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$395 | 53 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$288 | 62 BUY |
Advanced PGNY Option Strategies
Professional options setups generated by AI based on today's PGNY price and gamma walls.
